Resident, Fellow, and Preceptor Development Session: This is a special session for Residents, Fellows and Preceptors only.

Track:
General Session

Day & Time:
March 19, 11:30AM - 1:30PM

Room Number:
Deer/Scorpion Room

Type:
Session

Title:
Resident, Fellow, and Preceptor Development Session: This is a special session for Residents, Fellows and Preceptors only.

Chair(s):
Alicia Alexander Cadogan, PharmD
Director, Team Lead, Oncology
Pfizer Inc, United States

Description:
Pharmaceutical Industry-based Drug Information Residency and Fellowship programs are an important step towards ensuring that the future of Medical Communications in the pharmaceutical industry is in capable hands. There is no governing structure to standardize these programs, and as a result the experience and training received can vary greatly in content and expectations. Although the trainees must be engaged and committed to meet their goals, the preceptor is critical to the success of the programs, and critical to the preparedness of the trainee upon completion of their experience. For this DIA session, we invite Residents, Fellows, and their preceptors to join us as we explore the training experience from the perspective of both the trainee and the preceptor. We will discuss some optimal preceptor activities, share success stories and challenges, and explore the possibility of working together through DIA to provide more structure to this important career development path.

Presentation(s) & Speaker(s):
Faculty
Evelyn R. Hermes-DeSantis, PharmD
Clinical Professor, Ernest Mario School of Pharmacy
Rutgers, The State University of New Jersey, United States

Faculty
Gregory M Susla, PharmD,RPh
Associate Director, Coordinator Medical Information Residency Program
MedImmune, LLC, United States